I am a
Home I AM A Search Login

Papers of the Week


2019 Nov


Qual Life Res


28


11

Exploring the patient experience of locally advanced or metastatic pancreatic cancer to inform patient-reported outcomes assessment.

Authors

Herman JM, Kitchen H, Degboe A, Aldhouse NVJ, Trigg A, Hodgin M, Narang A, Johnson CD
Qual Life Res. 2019 Nov; 28(11):2929-2939.
PMID: 31273624.

Abstract

Pancreatic cancer and its treatments impact patients' symptoms, functioning, and quality of life. Content-valid patient-reported outcome (PRO) instruments are required to assess outcomes in clinical trials. This study aimed to: (a) conceptualise the patient experience of pancreatic cancer; (b) identify relevant PRO instruments; (c) review the content validity of mapped instruments to guide PRO measurement in clinical trials.